Member Info for Soupdragon78

Taz, it’s not so much about ‘MM’s being happy to take them all’ as they dropped the price significantly to do so. Plus why would your retail friends decide to sell millions now on the cusp of news?

The A trades amounted to about 13.5m in total, so even if they were all accumulated they haven't hit TR1 stage yet.

For the week we've seen 80.53m volume with 13.5m automated trades not through MM's. Overall 47% of all of 2022's volume has been this week, or 13% of the total shares in issue.

Really tricky to pin down, but for the past few days there has been direct market activity with someone constantly on the bid wanting shares. They've always been positioned just a fraction above the MM's bid price so have soaked up a lot (a good 8m+ from what I can tell but very difficult to know for sure).

Still up on the week if nothing else.

Looks like that flurry of activity spooked everyone away.

If someone is starting from scratch they need to accumulate about 18.5m shares before they need to TR1, very difficult to do without blowing the shareprice out of the water given how it reacts to volume.

Another way of looking at it is that 40% of the total volume for 2022 has occurred in the past 3 days.

Interesting leap.

Another nice day, good to have some volume to support an ongoing rise.

We have had volume of 58.086m since Monday morning, of which 10.042m have been automated trades not through market makers.

Anyone who bought yesterday afternoon is now selling for less than they bought.

They never learn

I’ll stick with just a happy ending.

Appreciate the sentiment, although I might swerve the offer of a 'fist pump' lol!

Interesting how Quotient and Oxilio both use the NFX RNS, I guess it saves them effort in writing out their own press releases.

https://www.quotientsciences.com/news/oxilio-signs-significant-service-contract-quotient-sciences-support-formulation-development-nxp-001/

https://www.oxilio.co.uk/news

Agree Kane, it was relatively quiet this morning, then all kicked off from 3 o’clock onwards with heavy buying.

The buying volume has certainly cranked up this afternoon.

At least they've advisors etc updated on the website now.

Busy day at NFX towers.

Apologies for the formatting.

CINV is separate to the oncology remit.

From the Allenby notes.

"If Oxilio decides not to exercise its option, NFX can reconsider its choices, likely via
licensing options rather than pursuing further internal development of NXP001. We note
that under the terms of the patent NFX has the opportunity to explore additional
indications and to seek partners for indications including CINV, dermatology and addiction
as well as oncology."

Maybe ask the company? Crazy I know!!

Says everything when someone just sold 482,229 for 30 quid profit which won't even cover their charges.

indeed goup, a couple of poor souls this morning bought and sold within 30 minutes, making a loss due to the spread.